Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-72.26	-44.27	159.57
Graham Fair Price	140.55	12.08	5.02
PEG	-98.67	< 0.005	0.16
Price/Book	-18.66	0.21	0.26
Price/Cash Flow	-91.28	4.50	51.57
Prices/Earnings	87.25	-1.07	-8.40
Price/Sales	40.20	2.17	1.55
Price/FCF	-91.28	4.50	51.57
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-47.21	-0.05	0.09
Operating Margin	754.18	-0.46	0.05
ROA	-521.58	-0.01	< 0.005
ROE	< 0.005	-0.05	-538.15
ROIC	< 0.005	-0.01	245.20
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	< 0.005	-23.72
Dividends QOQ	0.29	-0.14	-50.42
EBIT QOQ	1.53	-5.72	274.87
EPS QOQ	0.53	-5.08	856.08
FCF QOQ	2.39	7.88	229.98
Revenue QOQ	0.40	-0.45	12.54
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1070.80	1588.37	48.33
Days Sales Outstanding (DSO)	112.72	204.50	81.42
Inventory Turnover	0.08	0.06	-32.59
Debt/Capitalization	0.67	0.68	1.73
Quick Ratio	0.73	0.92	25.04
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	11.94	12.42	4.06
Cash	4.32	4.42	2.28
Capex	< 0.005	< 0.005	63.15
Free Cash Flow	0.06	0.54	788.22
Revenue	2.03	1.12	-44.75
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	3.21	3.27	1.93
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	137.85	-39.45	-71.38
Naive Interpretation	Member

06 - Financial Health · Bad

Rating